James D. Best

Lee Kong Chian School of Medicine

H指数:61

被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prevalence, risk factors and adverse health outcomes of osteosarcopenia in middle-aged and older adults with type 2 diabetes mellitus—a scoping review

中老年2型糖尿病人群中骨肌减少症的患病率、危险因素及不良健康结局——一项范围综述

Osteoporosis International

IF5.4

2026-10-030

PRE

The Health for Life in Singapore (HELIOS) Study: delivering precision medicine research for Asian populations

新加坡生命健康 (HELIOS) 研究: 为亚洲人群提供精准医学研究

Nature Communications

IF15.7

2025-12-300

OAAI

Xiaoyan Wang; Theresia Mina; Nilanjana Sadhu; Pritesh R. Jain; Hong Kiat Ng; Dorrain Yanwen Low; Darwin Tay; Terry Yoke Yin Tong; Wee-Lin Choo; Liming Lim; Swat Kim Kerk; Guo Liang Low; Benjamin Chih Chiang Lam; Rinkoo Dalan; Gervais Wanseicheong; Yik Weng Yew; Rob M. van Dam; Ee-J Leow; Soren Brage; Gregory A. Michelotti; Kari E. Wong; Patricia A. Sheridan; Pin Yan Low; Zhen Xuan Yeo; Nicolas Bertin; Claire Bellis; Maxime Hebrard; Pierre-Alexis Vincent Goy; Kostas Tsilidis; Harinakshi Sanikini; Xue Li Guan; Tock Han Lim; Lionel Lee; James D. Best; Patrick Tan; Paul Elliott; Eng Sing Lee; Jimmy Lee; Joanne Ngeow; Elio Riboli; Max Lam; Marie Loh; John C. Chambers

Metabolic variation reflects dietary exposure in a multi-ethnic Asian population

代谢变异反映了多民族亚洲人群的饮食暴露情况

Nature Metabolism

IF20.8

2025-09-170

PRE

Health literacy and guideline-adherent lifestyle in people with chronic kidney disease: exploring factors associated with usage intention of a structured m-health program and pilot data on actual behavior change

慢性肾病患者中的健康素养与指南依从性生活方式：探索与结构化m-health程序使用意向相关的因素及实际行为改变的试点数据

FRONTIERS IN NEPHROLOGY

IF0

2025-09-030

The association of haptoglobin levels and phenotype with cardiovascular disease in Type 2 diabetes: a Fenofibrate Intervention and Event Lowering in Diabetes sub-study

血红蛋白结合蛋白水平和表型与2型糖尿病中心血管疾病的关系：一项非诺贝特干预和糖尿病事件降低的子研究

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY

IF7.5

2025-09-011

OAAI

Metabolome-wide association identifies ferredoxin-1 (FDX1) as a determinant of cholesterol metabolism and cardiovascular risk in Asian populations

代谢组学关联分析确定了ferredoxin-1 (FDX1) 是亚洲人群中胆固醇代谢和心血管风险的决定因素。

cardiovascular research

IF10.8

2025-05-131

PRE

Sadhu, Nilanjana; Dalan, Rinkoo; Jain, Pritesh R.; Lee, Chang Jie Mick; Pakkiri, Leroy Sivappiragasam; Tay, Kai Yi; Mina, Theresia H.; Low, Dorrain; Min, Yilin; Ackers-Johnson, Matthew; Thi, Thi Tun; Kota, Vishnu Goutham; Shi, Yu; Liu, Yan; Yu, Hanry; Lai, Vicky; Yang, Yang; Tay, Darwin; Ng, Hong Kiat; Wang, Xiaoyan; Wong, Kari E.; Lam, Max; Guan, Xue Li; Bertin, Nicolas; Wong, Eleanor; Best, James; Sarangarajan, Rangaprasad; Elliott, Paul; Riboli, Elio; Lee, Jimmy; Lee, Eng Sing; Ngeow, Joanne; Tan, Patrick; Cheung, Christine; Drum, Chester Lee; Foo, Roger S. Y.; Michelotti, Gregory A.; Yu, Haojie; Sheridan, Patricia A.; Loh, Marie; Chambers, John C.

Risk Models for the Development of Cardiovascular and Microvascular Events in Adults with Type 2 Diabetes in the FIELD Study

DIABETES

IF7.5

2023-06-200

PRE

Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetes

SCIENTIFIC REPORTS

IF3.9

2021-09-211

OAAI

STEM CELL THERAPY FOR THE TREATMENT OF ERECTILE DYSFUNCTION AND PEYRONIE'S DISEASE: A SURVEY OF STEM CELL CLINICS ACROSS THE USA

JOURNAL OF SEXUAL MEDICINE